Chemotherapy‐induced skin toxicity and capillary leak syndrome

Background The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS. Methods Leukemia or hematopoietic stem cell transplant patients between January 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of dermatology 2019-07, Vol.58 (7), p.856-860
Hauptverfasser: Hunjan, Manrup K., Nowsheen, Somaira, Ramos‐Rodriguez, Alvaro J., Bridges, Alina G., Lehman, Julia S., Hashmi, Shahrukh K., el‐Azhary, Rokea A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 860
container_issue 7
container_start_page 856
container_title International journal of dermatology
container_volume 58
creator Hunjan, Manrup K.
Nowsheen, Somaira
Ramos‐Rodriguez, Alvaro J.
Bridges, Alina G.
Lehman, Julia S.
Hashmi, Shahrukh K.
el‐Azhary, Rokea A.
description Background The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS. Methods Leukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS. Results Five patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation. Conclusions Although TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.
doi_str_mv 10.1111/ijd.14392
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2233699596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2233699596</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3532-14a3c6eb1953bad12ae9949df96f454953ca6a03135edf5982fb5be00298911a3</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EoqWw4AIoEisWaf0MmR2ovIoqsYG15cSO6jaPYieC7DgCZ-QkGALsmM1oRp_-GX0IHRM8JaFmdq2nhDOgO2hMWCJinjC6i8YYExIDFjBCB96vw8go4ftoxHDKz1OgY3QxX5mqaVfGqW3_8fZua93lRkd-Y-uobV5tbts-UrWOcrW1ZalcH5VGbSLf19o1lTlEe4UqvTn66RP0dHP9OL-Llw-3i_nlMs6ZYDQmXLE8MRkBwTKlCVUGgIMuICm44GGbq0RhRpgwuhCQ0iITmcGYQgqEKDZBp0Pu1jXPnfGtXDedq8NJSSljCYCAJFBnA5W7xntnCrl1tgpPS4LllysZXMlvV4E9-UnsssroP_JXTgBmA_BiS9P_nyQX91dD5Cex6XMu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2233699596</pqid></control><display><type>article</type><title>Chemotherapy‐induced skin toxicity and capillary leak syndrome</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hunjan, Manrup K. ; Nowsheen, Somaira ; Ramos‐Rodriguez, Alvaro J. ; Bridges, Alina G. ; Lehman, Julia S. ; Hashmi, Shahrukh K. ; el‐Azhary, Rokea A.</creator><creatorcontrib>Hunjan, Manrup K. ; Nowsheen, Somaira ; Ramos‐Rodriguez, Alvaro J. ; Bridges, Alina G. ; Lehman, Julia S. ; Hashmi, Shahrukh K. ; el‐Azhary, Rokea A.</creatorcontrib><description>Background The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS. Methods Leukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS. Results Five patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation. Conclusions Although TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.14392</identifier><identifier>PMID: 30847892</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Chemotherapy ; Consultation ; Dermatology ; Diagnosis ; Erythema ; Hematopoietic stem cells ; Leukemia ; Medical records ; Patients ; Skin ; Stem cells ; Toxic epidermal necrolysis ; Toxicity</subject><ispartof>International journal of dermatology, 2019-07, Vol.58 (7), p.856-860</ispartof><rights>2019</rights><rights>2019 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2019 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3532-14a3c6eb1953bad12ae9949df96f454953ca6a03135edf5982fb5be00298911a3</citedby><cites>FETCH-LOGICAL-c3532-14a3c6eb1953bad12ae9949df96f454953ca6a03135edf5982fb5be00298911a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.14392$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.14392$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30847892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hunjan, Manrup K.</creatorcontrib><creatorcontrib>Nowsheen, Somaira</creatorcontrib><creatorcontrib>Ramos‐Rodriguez, Alvaro J.</creatorcontrib><creatorcontrib>Bridges, Alina G.</creatorcontrib><creatorcontrib>Lehman, Julia S.</creatorcontrib><creatorcontrib>Hashmi, Shahrukh K.</creatorcontrib><creatorcontrib>el‐Azhary, Rokea A.</creatorcontrib><title>Chemotherapy‐induced skin toxicity and capillary leak syndrome</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description>Background The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS. Methods Leukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS. Results Five patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation. Conclusions Although TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.</description><subject>Chemotherapy</subject><subject>Consultation</subject><subject>Dermatology</subject><subject>Diagnosis</subject><subject>Erythema</subject><subject>Hematopoietic stem cells</subject><subject>Leukemia</subject><subject>Medical records</subject><subject>Patients</subject><subject>Skin</subject><subject>Stem cells</subject><subject>Toxic epidermal necrolysis</subject><subject>Toxicity</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kEtOwzAQhi0EoqWw4AIoEisWaf0MmR2ovIoqsYG15cSO6jaPYieC7DgCZ-QkGALsmM1oRp_-GX0IHRM8JaFmdq2nhDOgO2hMWCJinjC6i8YYExIDFjBCB96vw8go4ftoxHDKz1OgY3QxX5mqaVfGqW3_8fZua93lRkd-Y-uobV5tbts-UrWOcrW1ZalcH5VGbSLf19o1lTlEe4UqvTn66RP0dHP9OL-Llw-3i_nlMs6ZYDQmXLE8MRkBwTKlCVUGgIMuICm44GGbq0RhRpgwuhCQ0iITmcGYQgqEKDZBp0Pu1jXPnfGtXDedq8NJSSljCYCAJFBnA5W7xntnCrl1tgpPS4LllysZXMlvV4E9-UnsssroP_JXTgBmA_BiS9P_nyQX91dD5Cex6XMu</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Hunjan, Manrup K.</creator><creator>Nowsheen, Somaira</creator><creator>Ramos‐Rodriguez, Alvaro J.</creator><creator>Bridges, Alina G.</creator><creator>Lehman, Julia S.</creator><creator>Hashmi, Shahrukh K.</creator><creator>el‐Azhary, Rokea A.</creator><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>201907</creationdate><title>Chemotherapy‐induced skin toxicity and capillary leak syndrome</title><author>Hunjan, Manrup K. ; Nowsheen, Somaira ; Ramos‐Rodriguez, Alvaro J. ; Bridges, Alina G. ; Lehman, Julia S. ; Hashmi, Shahrukh K. ; el‐Azhary, Rokea A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3532-14a3c6eb1953bad12ae9949df96f454953ca6a03135edf5982fb5be00298911a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Chemotherapy</topic><topic>Consultation</topic><topic>Dermatology</topic><topic>Diagnosis</topic><topic>Erythema</topic><topic>Hematopoietic stem cells</topic><topic>Leukemia</topic><topic>Medical records</topic><topic>Patients</topic><topic>Skin</topic><topic>Stem cells</topic><topic>Toxic epidermal necrolysis</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunjan, Manrup K.</creatorcontrib><creatorcontrib>Nowsheen, Somaira</creatorcontrib><creatorcontrib>Ramos‐Rodriguez, Alvaro J.</creatorcontrib><creatorcontrib>Bridges, Alina G.</creatorcontrib><creatorcontrib>Lehman, Julia S.</creatorcontrib><creatorcontrib>Hashmi, Shahrukh K.</creatorcontrib><creatorcontrib>el‐Azhary, Rokea A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hunjan, Manrup K.</au><au>Nowsheen, Somaira</au><au>Ramos‐Rodriguez, Alvaro J.</au><au>Bridges, Alina G.</au><au>Lehman, Julia S.</au><au>Hashmi, Shahrukh K.</au><au>el‐Azhary, Rokea A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemotherapy‐induced skin toxicity and capillary leak syndrome</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>58</volume><issue>7</issue><spage>856</spage><epage>860</epage><pages>856-860</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>Background The occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS. Methods Leukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS. Results Five patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation. Conclusions Although TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>30847892</pmid><doi>10.1111/ijd.14392</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-9059
ispartof International journal of dermatology, 2019-07, Vol.58 (7), p.856-860
issn 0011-9059
1365-4632
language eng
recordid cdi_proquest_journals_2233699596
source Wiley Online Library Journals Frontfile Complete
subjects Chemotherapy
Consultation
Dermatology
Diagnosis
Erythema
Hematopoietic stem cells
Leukemia
Medical records
Patients
Skin
Stem cells
Toxic epidermal necrolysis
Toxicity
title Chemotherapy‐induced skin toxicity and capillary leak syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A42%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemotherapy%E2%80%90induced%20skin%20toxicity%20and%20capillary%20leak%20syndrome&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Hunjan,%20Manrup%20K.&rft.date=2019-07&rft.volume=58&rft.issue=7&rft.spage=856&rft.epage=860&rft.pages=856-860&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.14392&rft_dat=%3Cproquest_cross%3E2233699596%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2233699596&rft_id=info:pmid/30847892&rfr_iscdi=true